| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 37.81 | 11.6% | 7.1% |
| Total Income | 38.84 | 12.6% | 7.5% |
| Expenditure | 40.86 | 6.7% | 0.2% |
| PBT | -2.22 | 446.9% | 187.1% |
| Net Profit | -0.86 | 8700.0% | 132.8% |
| OPM | -1.30% | 5.48pp | 2.90pp |
| NPM | -2.21% | 2.23pp | 6.76pp |
| EPS | 1.15 | 11400.0% | 67.3% |
Dai-Ichi Karkaria Ltd. Announces Q3 FY25-26 Results with Enhanced Oilfield Chemicals Production
06 Feb 2026 · 6 Feb, 7:35 pm
Summary
Dai-Ichi Karkaria Ltd., a specialty chemicals company, has announced its Q3 FY25-26 results. The company has been producing high-performance speciality chemicals for various industrial applications since 1963, with a focus on sustainability and innovation. The company has a strong commitment to quality control and innovation, and has achieved several milestones over the years.
Key Highlights
- 1
Commenced production in 1963 in technical collaboration with Dai-ichi Kogyo Seiyaku based in Japan
- 2
Develop and manufacture high-performance speciality chemicals for various industrial applications
- 3
Market innovative products, providing custom solutions tailored to our client’s needs
- 4
Work towards creating products and processes that are clean, reflecting the integrity of our manufacturing process, with minimum use of hazardous chemicals and efficient chemical synthesis
- 5
Quality Control: Batch-to-batch consistencies are maintained by rigorous, regular and complete testing at every stage
- 6
Innovation: Focus on product design, process efficiency and environmental health & safety
- 7
JV is created for the manufacture of oilfield chemicals with enhanced capacities
- 8
Acquired 40% stake of Champion Pharma products with Baker Biosciences
- 9
Formed a JV with GVK Biosciences subsidiary of Dai-ichi for the manufacture of chemical sector Oilfield chemicals
Management Comments
Ankit Parimal Shah
Company Secretary and Compliance officer
Informational and educational content only. Not investment advice.